334 related articles for article (PubMed ID: 9464945)
1. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma.
Singh B; Bhaya M; Zimbler M; Stern J; Roland JT; Rosenfeld RM; Har-El G; Lucente FE
Head Neck; 1998 Jan; 20(1):1-7. PubMed ID: 9464945
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study.
Singh B; Bhaya M; Stern J; Roland JT; Zimbler M; Rosenfeld RM; Har-El G; Lucente FE
Laryngoscope; 1997 Nov; 107(11 Pt 1):1469-75. PubMed ID: 9369392
[TBL] [Abstract][Full Text] [Related]
4. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
[TBL] [Abstract][Full Text] [Related]
5. Development of a new head and neck cancer-specific comorbidity index.
Piccirillo JF; Lacy PD; Basu A; Spitznagel EL
Arch Otolaryngol Head Neck Surg; 2002 Oct; 128(10):1172-9. PubMed ID: 12365889
[TBL] [Abstract][Full Text] [Related]
6. The impact of compliance in posttreatment surveillance in head and neck squamous cell carcinoma.
Deutschmann MW; Sykes KJ; Harbison J; Cabrera-Muffly C; Shnayder Y
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):519-25. PubMed ID: 25950859
[TBL] [Abstract][Full Text] [Related]
7. Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice.
Paleri V; Wight RG; Silver CE; Haigentz M; Takes RP; Bradley PJ; Rinaldo A; Sanabria A; Bień S; Ferlito A
Oral Oncol; 2010 Oct; 46(10):712-9. PubMed ID: 20850371
[TBL] [Abstract][Full Text] [Related]
8. A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck.
Verschuur HP; Irish JC; O'Sullivan B; Goh C; Gullane PJ; Pintilie M
Laryngoscope; 1999 Feb; 109(2 Pt 1):249-58. PubMed ID: 10890775
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma.
Park MJ; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2018 Mar; 92():69-76. PubMed ID: 29428866
[TBL] [Abstract][Full Text] [Related]
10. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
11. Survival outcomes of patients with advanced oral cavity squamous cell carcinoma treated with multimodal therapy: a multi-institutional analysis.
Zhang H; Dziegielewski PT; Biron VL; Szudek J; Al-Qahatani KH; O'Connell DA; Harris JR; Seikaly H
J Otolaryngol Head Neck Surg; 2013 Apr; 42(1):30. PubMed ID: 23672952
[TBL] [Abstract][Full Text] [Related]
12. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
Chang CL; Yuan KS; Wu SY
Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
[TBL] [Abstract][Full Text] [Related]
13. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
[TBL] [Abstract][Full Text] [Related]
16. Multivariate analysis of potential risk factors for lymph node metastasis in patients with cutaneous squamous cell carcinoma of the head and neck.
Haisma MS; Plaat BEC; Bijl HP; Roodenburg JLN; Diercks GFH; Romeijn TR; Terra JB
J Am Acad Dermatol; 2016 Oct; 75(4):722-730. PubMed ID: 27473455
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
18. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma.
Aboshanif M; Kawasaki Y; Omori Y; Suzuki S; Honda K; Motoyama S; Ishikawa K
Diagn Pathol; 2016 Aug; 11(1):79. PubMed ID: 27539087
[TBL] [Abstract][Full Text] [Related]
20. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]